Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Oncology, N. CML: In chronischer Phase schützt Nilotinib besser vor Progression. Info Onkol. 13, 53 (2010). https://doi.org/10.1007/BF03362825
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03362825